Biotech Hepion Pharmaceuticals Announces Early Completion of Enrollment in Phase 2 ‘ALTITUDE-NASH’ Liver Function Trial December 5, 2022
Biotech Corvus Pharmaceuticals to Host Investor Conference Call and Webcast on December 12, 2022 December 5, 2022
Biotech Eiger BioPharmaceuticals Class Action Deadline Alert: Johnson Fistel Encourages Shareholders to Submit Their EIGR Losses December 5, 2022
Biotech CNS Pharmaceuticals to Participate at the Virtual Investor “Ask the CEO” Event December 5, 2022
Biotech AnPac Announces Strategic Initiative to Establish A Wholly-Owned Subsidiary for US Food Market December 5, 2022
Biotech Aridis Signs Exclusive Terms to Secure Worldwide Commercial Licenses for Pan-Ebola and Pan-Marburg Monoclonal Antibody Programs from Mapp Biopharmaceutical December 5, 2022
Biotech NanoViricides, Inc. to Present at the RHK Capital Disruptive Growth Conference in New York City on December 6th at 1:20pm ET December 5, 2022